
|Articles|November 1, 2007
B&L merger approved
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
Advertisement
Bausch & Lomb's shareholders have voted to approve a merger with Warburg Pincus.
In accordance with the terms of the merger, each outstanding share of common and Class B stock will be cancelled and converted into the right to receive $65 in cash, without interest, less any applicable withholding taxes.
The merger is expected to close early in the fourth quarter of this year.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
5






















